Kairos Pharma (KAPA) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by CEO and Chairman John Yu, with executive officers introduced and agenda distributed to attendees.

• Matters to be voted on included director elections, auditor ratification, reverse stock split, executive compensation, and equity plan amendments.

Shareholder proposals

• Proposals included election of four directors, ratification of auditors, approval of a reverse stock split, advisory approval of executive compensation, and amendments to the equity incentive plan.

• Motions to approve all proposals were made and seconded by stockholders Neil Bhowmick and Ramachandran Murali.

Overview of voting outcomes

• All director nominees were elected to the board.

• Auditor ratification, reverse stock split amendment, executive compensation, and equity incentive plan amendments (including a 5 million share increase and 10-year evergreen provision) were all approved.

• Final voting results will be reported in a Form 8-K filing with the SEC within four business days.